SEC Company Response from CRESCENT BIOPHARMA, INC. (CBIO) (CIK 0001253689) (CBIO) — Nov 5, 2013
CRESCENT BIOPHARMA, INC. (CBIO) (CIK 0001253689)
Date: Nov. 5, 2013 · CIK: 0001253689 · Accession: 0001193125-13-427591
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-191567
Letter
Re: GlycoMimetics, Inc. (the “Company”) – Request for Acceleration
Correspondence
November 5, 2013
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (File No. 333-191567)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as Representatives of the several underwriters of the Company’s proposed public offering of common shares, we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, as amended, requesting effectiveness for 4:00 p.m. Eastern Time on November 7, 2013, or as soon thereafter as is practicable.
Pursuant to Rule 460 of the Act, we wish to advise you that we have distributed approximately 3,105 copies of the Company’s Preliminary Prospectus dated October 28, 2013 through the date hereof to underwriters, dealers, institutions and others.
We, the undersigned, as Representatives of the several underwriters, have and will, and we have been informed by the participating underwriters that they have complied and will continue to comply, with the provisions of Rule 15c2-8 of the Securities Exchange Act of 1934, as amended.
[Signature Page Follows]
Very truly yours,
Jefferies LLC
Show Raw Text
CORRESP 1 filename1.htm Correspondence November 5, 2013 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: GlycoMimetics, Inc. (the “Company”) – Request for Acceleration Registration Statement on Form S-1 (File No. 333-191567) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as Representatives of the several underwriters of the Company’s proposed public offering of common shares, we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, as amended, requesting effectiveness for 4:00 p.m. Eastern Time on November 7, 2013, or as soon thereafter as is practicable. Pursuant to Rule 460 of the Act, we wish to advise you that we have distributed approximately 3,105 copies of the Company’s Preliminary Prospectus dated October 28, 2013 through the date hereof to underwriters, dealers, institutions and others. We, the undersigned, as Representatives of the several underwriters, have and will, and we have been informed by the participating underwriters that they have complied and will continue to comply, with the provisions of Rule 15c2-8 of the Securities Exchange Act of 1934, as amended. [Signature Page Follows] Very truly yours, Jefferies LLC Barclays Capital Inc. As Representatives of the several Underwriters By: Jefferies LLC By: /s/ Ashley Delp Name: Ashley Delp Title: Managing Director By: Barclays Capital Inc. By: /s/ Victoria Hale Name: Victoria Hale Title: Vice President